Namwiwat Medical Corporation PCL (BKK:NAM)
Thailand · Delayed Price · Currency is THB 3.800
0.00 (0.00%)
At close: Feb 10, 2026
BKK:NAM Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 127.49 | 180.87 | 200.75 | 175.71 | 174.65 | 111.83 |
Depreciation & Amortization | 43.73 | 30.57 | 28.61 | 20.41 | 17.67 | - |
Other Amortization | 13.69 | 7.25 | 1.02 | 0.9 | 0.41 | 0.34 |
Loss (Gain) From Sale of Assets | 2.43 | 0.14 | -10.28 | -5.44 | -1.22 | -0.16 |
Asset Writedown & Restructuring Costs | - | - | -1.23 | 2.35 | 0.42 | 17.6 |
Loss (Gain) From Sale of Investments | -1.04 | -1.96 | -2.16 | -0.59 | - | -10.65 |
Loss (Gain) on Equity Investments | - | - | - | 0.55 | 0.27 | 11.4 |
Provision & Write-off of Bad Debts | 4.11 | 5.85 | -7.09 | -6.56 | 10.78 | -0.99 |
Other Operating Activities | 34.81 | 16.63 | 10.67 | -3.92 | 24.3 | 13.46 |
Change in Accounts Receivable | 72.18 | -242.45 | 52.85 | -194.59 | -11.15 | -14.81 |
Change in Inventory | -184 | -80.69 | 17.12 | 27.96 | -203.31 | -87.6 |
Change in Accounts Payable | -142.16 | 75.39 | -54.37 | 25.53 | 53.17 | -12.14 |
Change in Unearned Revenue | 0.53 | 0.63 | -14.62 | 0.64 | 6.18 | 23.47 |
Change in Other Net Operating Assets | 109.86 | 20.74 | 37.43 | -124.13 | 21.45 | 52.95 |
Operating Cash Flow | 81.63 | 12.95 | 258.68 | -81.16 | 93.61 | 104.71 |
Operating Cash Flow Growth | 73.23% | -94.99% | - | - | -10.60% | - |
Capital Expenditures | -37.87 | -55.57 | -30.41 | - | - | - |
Sale of Property, Plant & Equipment | - | 0.41 | 1.12 | - | - | - |
Cash Acquisitions | -140.08 | -33.05 | - | - | - | - |
Sale (Purchase) of Intangibles | -26.96 | -22.87 | -8.42 | -53.6 | -0.97 | -0.65 |
Sale (Purchase) of Real Estate | - | - | - | -38.44 | -31.33 | -178.77 |
Investment in Securities | 19.89 | 44.93 | 200 | -300 | - | 35.2 |
Other Investing Activities | 34.79 | 2.12 | - | - | - | - |
Investing Cash Flow | -150.23 | -64.03 | 162.28 | -392.04 | -32.3 | -144.22 |
Short-Term Debt Issued | - | 3.89 | - | - | 5 | 33 |
Long-Term Debt Issued | - | 122.5 | - | - | 24 | 115 |
Total Debt Issued | 361.1 | 126.39 | - | - | 29 | 148 |
Short-Term Debt Repaid | - | - | - | -67.62 | -34.88 | -75.99 |
Long-Term Debt Repaid | - | -99.15 | -36.35 | -37.69 | -43.05 | -37.39 |
Total Debt Repaid | -429.85 | -99.15 | -36.35 | -105.31 | -77.93 | -113.39 |
Net Debt Issued (Repaid) | -68.76 | 27.24 | -36.35 | -105.31 | -48.93 | 34.61 |
Issuance of Common Stock | - | - | 784.08 | 839.39 | - | - |
Common Dividends Paid | -106.2 | -62.99 | -232.05 | -242.5 | - | - |
Other Financing Activities | - | 12 | 0 | - | - | - |
Financing Cash Flow | -174.96 | -23.74 | 515.67 | 491.58 | -48.93 | 34.61 |
Net Cash Flow | -243.56 | -74.82 | 936.64 | 18.38 | 12.38 | -4.9 |
Free Cash Flow | 43.76 | -42.62 | 228.27 | -81.16 | 93.61 | 104.71 |
Free Cash Flow Growth | - | - | - | - | -10.60% | - |
Free Cash Flow Margin | 2.45% | -3.82% | 20.69% | -7.38% | 9.40% | 15.43% |
Free Cash Flow Per Share | 0.06 | -0.06 | 0.37 | -3.09 | 4.68 | 5.24 |
Cash Interest Paid | 25.14 | 12.92 | 14.05 | 13.45 | 11.2 | 8.69 |
Cash Income Tax Paid | 51.27 | 39.35 | 50.71 | 54.5 | 29.14 | 16.17 |
Levered Free Cash Flow | -322.61 | -161.46 | 182.37 | -173.57 | 38.41 | - |
Unlevered Free Cash Flow | -307.1 | -153.53 | 192.2 | -165.46 | 47.19 | - |
Change in Working Capital | -143.59 | -226.39 | 38.4 | -264.59 | -133.67 | -38.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.